Urinary leukotriene E4 levels increase upon exposure to hypobaric hypoxia

Chest

Volumn 110, Issue 4, 1996, Pages 946-951

  Roach, James M ^a,b,c   Muza, Stephen R ^a   Rock, Paul B ^a   Lyons, Timothy P ^a   Lilly, Craig M ^b   Drazen, Jeffrey M ^b   Cymerman, Allen ^a  

^a U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Astra USA   (United States)

Author keywords

altitude; altitude sickness; leukotrienes

Indexed keywords

LEUKOTRIENE E4;

ADULT; ALTITUDE DISEASE; ARTICLE; CLINICAL TRIAL; ENVIRONMENTAL EXPOSURE; HUMAN; HUMAN EXPERIMENT; HYPOBARISM; MALE; NORMAL HUMAN; OXYGEN SATURATION; PRIORITY JOURNAL; PULSE OXIMETRY; QUESTIONNAIRE; SYMPTOMATOLOGY; UNITED STATES; URINALYSIS; URINE LEVEL; ALTITUDE; ANOXIA; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; URINE;

ADULT; ALTITUDE; ALTITUDE SICKNESS; ANOXIA; HUMANS; LEUKOTRIENE E4; MALE; PROSPECTIVE STUDIES;

EID: 0029662335     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.4.946     Document Type: Article

References (21)

1. Bezruchka S. High altitude medicine. Med Clin North Am 1992; 76:1481-97
2. Honigman B, Theis MK, Koziol-McLain J, et al. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med 1993; 118:587-92
3. Johnson TS, Rock PB. Acute mountain sickness. N Engl J Med 1988; 319:841-45
4. Singh I, Khanna PK, Srivastava MC, et al. Acute mountain sickness. N Engl J Med 1969; 280:175-83
5. Johnson TS, Rock PB, Fulco CS, et al. Prevention of acute mountain sickness by dexamethasone. N Engl J Med 1984; 310:683-86
6. Lewis RE, Granger HJ. Diapedesis and the permeability of venous microvessels to protein macromolecules: the impact of leukotriene B4 (LTB4). Microvasc Res 1988; 35:27-47
7. Inoue H, Mori T, Koshihara Y. Sulfidopeptide-leukotrienes are major mediators of arachidonic acid induced mouse ear edema. Prostaglandins 1988; 36:731-39
8. Tanaka H, Bradley JD, Baudendistel LJ, et al. Mechanisms of increased pulmonary microvascular permeability induced by FMLP in isolated rabbit lungs. J Appl Physiol 1992; 73:2074-82
9. Richalet JP, Hornych A, Rathat C, et al. Plasma prostaglandins, leukotrienes and thromboxane in acute high altitude hypoxia. Respir Physiol 1991; 85:205-15
10. Westcott JY, Johnston K, Batt RA, et al. Measurement of peptidoleukotrienes in biological fluids. J Appl Physiol 1990; 68:2640-48
11. 4 from the urine of patients with airway obstruction. Am Rev Respir Dis 1992; 146:104-08
12. Kobrick JL, Sampson JB. New inventory for the assessment of symptom occurrence and severity at high altitude. Aviat Space Environ Med 1995; 50:925-29
13. Sampson JB, Cymerman A, Burse RL, et al. Procedures for the measurement of acute mountain sickness. Aviat Space Environ Med 1983; 54:1063-73
14. Meehan RT, Cymerman A, Rock P, et al. The effect of naproxen on acute mountain sickness and vascular responses to hypoxia. Am J Med Sci 1986; 29:15-20
15. Ellsworth AJ, Meyer EF, Larson EB. Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier. West J Med 1991; 154:289-93
16. Rock PB, Johnson TS, Cymerman A, et al. Effect of dexamethasone on symptoms of acute mountain sickness at Pikes Peak. Colorado (4,300 m). Aviat Space Environ Med 1987; 58:668-72
17. Ellsworth AJ, Larson EB, Strickland D. A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis. Am J Med 1987; 83:1024-30
18. Montgomery AB, Luce JM, Michael P, et al. Effects of deximethasone on the incidence of acute mountain sickness at two intermediate altitudes. JAMA 1989; 261:734-36
19. Levine BD, Yoshimura K, Kobayashi T, et al. Dexamethasone in the treatment of acute mountain sickness. N Engl J Med 1989; 321:1707-13
20. Hackett PH, Roach RC, Wood RA, et al. Dexamethasone for prevention and treatment of acute mountain sickness. Aviat Space Environ Med 1988; 59:950-54
21. Ferrazzini G, Maffiorini M, Kriemler S, et al. Successful treatment of acute mountain sickness with dexamethasone. BMJ 1987; 294:1380-82